Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly targeting tyrosine kinases involved in cancer cell signaling pathways. Shows potential in the development of targeted therapies for solid tumors due to its ability to modulate specific protein interactions. Also employed in the design of PROTACs (proteolysis-targeting chimeras) to promote degradation of disease-causing proteins. Its structure supports high binding affinity and selectivity, making it valuable in optimizing drug candidates for improved efficacy and reduced off-target effects.